logo

For the Inventor, By the Inventor

Edmonton, Canada

Chembiomed, Ltd.


USPTO Granted Patents = 17


Forward Citations = 336

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Raymond U Lemieux (8 out of 11 patents)

silverMedal Donald A Baker (6 out of 10 patents)

bronzeMedal M Abdul Mazid (4 out of 6 patents)

4.  Robert M Ratcliffe (4 out of 4 patents)

5.  R Murray Ratcliffe (3 out of 3 patents)

6.  Ole Hindsgaul (2 out of 29 patents)

7.  David R Bundle (2 out of 4 patents)

8.  James Pierce (2 out of 5 patents)

9.  Wolfgang Mundt (1 out of 63 patents)

10.  Richard H Smith (1 out of 17 patents)

11.  Nai-Hong Li (1 out of 9 patents)

12.  Uwe B Sleytr (1 out of 2 patents)

13.  Mohammed A Kashem (1 out of 10 patents)

14.  Paul Messner (1 out of 1 patent)

15.  Frank M Unger (1 out of 1 patent)


17 patents:

1. 5240601 - Affinity supports for hemoperfusion (1993-08-31),
2. 5206356 - Inhibitors for alpha-L-fucosyl transferase (1993-04-27),
3. 5168104 - Macroporous particles as biocompatible chromatographic supports (1992-12-01),
4. 5149425 - Affinity supports for hemoperfusion (1992-09-22),
5. 5079353 - Sialic acid glycosides, antigens, immunoadsorbents, and methods for (1992-01-07),
6. 5059535 - Process for the separation and purification of sialyl transferases (1991-10-22),
7. 5043158 - Immunogenic compositions containing ordered carriers (1991-08-27),
8. 5032505 - Inhibitors for glycosaminosyl transferase V (1991-07-16),
9. 4866041 - Synthesis of tumor antigenic determinant (1989-09-12),
10. 4855126 - Method to detect T-antigen delayed hypersensitivity (1989-08-08),
11. 4794176 - Synthesis of tumor antigenic determinant (1988-12-27),
12. 4767845 - Synthesis of tumor antigenic determinant (1988-08-30),
13. 4362720 - Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from (1982-12-07),
14. 4308376 - Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from (1981-12-29),
15. 4238473 - Artificial oligosaccharide antigenic determinants (1980-12-09),
Company Overview
Chembiomed, Ltd. is a biotechnology company based in Edmonton, Canada, specializing in the development of innovative therapeutic solutions. The organization focuses on harnessing advanced biochemistry and molecular biology techniques to create novel treatments for various medical conditions. With a commitment to research and development, Chembiomed aims to address unmet medical needs through its cutting-edge technologies and collaborative efforts in the life sciences sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

17 Patents

#15 in Edmonton

#884 in Canada

#35,948 in the World

Edmonton, CA
Edmonton, Canada

Chembiomed, Ltd.

Forward Citations = 336

18 inventors:

goldMedal Raymond U Lemieux (8 out of 11 patents)

silverMedal Donald A Baker (6 out of 10 patents)

bronzeMedal M Abdul Mazid (4 out of 6 patents)

4.  Robert M Ratcliffe (4 out of 4 patents)

5.  R Murray Ratcliffe (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chembiomed, Ltd.. Retrieved from https://idiyas.com/company/chembiomed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…